Mostrar el registro sencillo del ítem
Epithelial-mesenchymal transition in non small-cell lung cancer
dc.creator | Tsoukalas N., Aravantinou-Fatorou E., Tolia M., Giaginis C., Galanopoulos M., Kiakou M., Kostakis I.D., Dana E., Vamvakaris I., Korogiannos A., Tsiambas E., Salemis N., Kyrgias G., Karameris A., Theocharis S. | en |
dc.date.accessioned | 2023-01-31T10:19:11Z | |
dc.date.available | 2023-01-31T10:19:11Z | |
dc.date.issued | 2017 | |
dc.identifier | 10.21873/anticanres.11510 | |
dc.identifier.issn | 02507005 | |
dc.identifier.uri | http://hdl.handle.net/11615/80152 | |
dc.description.abstract | Background/Aim: Lung cancer is the first cause of cancer related deaths in both males and females. Epithelial-mesenchymal transition (EMT) is a reversible process by which epithelial cells transform to mesenchymal stem cells by losing their cell polarity and cell-to-cell adhesion, gaining migratory and invasive properties. High levels of E-cadherin are expressed in epithelial cells, whereas mesenchymal cells express high levels of N-cadherin, fibronectin and vimentin. The aim of this study was to evaluate the correlation between E-cadherin and vimentin expression and their clinical significance in non-small cell lung cancer (NSCLC). Materials and Methods: The immunohistochemical expression of E-cadherin, vimentin and Ki-67 was performed on tissue microarrays from NSCLC specimens obtained from 112 newly-diagnosed cases and were studied using classical pathological evaluation. Associations between E-cadherin, vimentin and Ki-67 expression, clinicopathological variables and survival were analyzed. In all cases, a value of p=0.05 was considered significant. Results: Low E-cadherin expression was significantly correlated with tumor necrosis (p=0.019). Moreover, there was a trend for correlation between high E-cadherin expression and better overall survival (hazard ratio=1.02, and 95% confidence interval=0.45-1.87, p=0.091). There was also a significant negative correlation between vimentin expression and overall survival (hazard ratio=1.13, and 95% confidence interval=0.78-1.65, p=0.026). Additionally, there was a significant negative correlation between vimentin expression and grade I tumors (p=0.031). Finally, a positive correlation trend between vimentin expression and Ki-67 was found (p=0.073). Conclusion: High E-cadherin and low vimentin expression correlate with better prognosis and overall survival. | en |
dc.language.iso | en | en |
dc.source | Anticancer Research | en |
dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85017469396&doi=10.21873%2fanticanres.11510&partnerID=40&md5=267732dbcc5245c1acf57492c2e2e86f | |
dc.subject | Ki 67 antigen | en |
dc.subject | uvomorulin | en |
dc.subject | vimentin | en |
dc.subject | cadherin | en |
dc.subject | CDH1 protein, human | en |
dc.subject | fibronectin | en |
dc.subject | FN1 protein, human | en |
dc.subject | tumor marker | en |
dc.subject | vimentin | en |
dc.subject | adult | en |
dc.subject | aged | en |
dc.subject | Article | en |
dc.subject | cancer survival | en |
dc.subject | controlled study | en |
dc.subject | correlation analysis | en |
dc.subject | epithelial mesenchymal transition | en |
dc.subject | evaluation study | en |
dc.subject | female | en |
dc.subject | human | en |
dc.subject | major clinical study | en |
dc.subject | male | en |
dc.subject | non small cell lung cancer | en |
dc.subject | overall survival | en |
dc.subject | priority journal | en |
dc.subject | protein expression | en |
dc.subject | tissue microarray | en |
dc.subject | tumor necrosis | en |
dc.subject | adenocarcinoma | en |
dc.subject | cancer staging | en |
dc.subject | enzyme immunoassay | en |
dc.subject | follow up | en |
dc.subject | large cell carcinoma | en |
dc.subject | lung tumor | en |
dc.subject | metabolism | en |
dc.subject | middle aged | en |
dc.subject | non small cell lung cancer | en |
dc.subject | pathology | en |
dc.subject | prognosis | en |
dc.subject | squamous cell carcinoma | en |
dc.subject | survival rate | en |
dc.subject | tumor invasion | en |
dc.subject | very elderly | en |
dc.subject | Adenocarcinoma | en |
dc.subject | Adult | en |
dc.subject | Aged | en |
dc.subject | Aged, 80 and over | en |
dc.subject | Biomarkers, Tumor | en |
dc.subject | Cadherins | en |
dc.subject | Carcinoma, Large Cell | en |
dc.subject | Carcinoma, Non-Small-Cell Lung | en |
dc.subject | Carcinoma, Squamous Cell | en |
dc.subject | Epithelial-Mesenchymal Transition | en |
dc.subject | Female | en |
dc.subject | Fibronectins | en |
dc.subject | Follow-Up Studies | en |
dc.subject | Humans | en |
dc.subject | Immunoenzyme Techniques | en |
dc.subject | Lung Neoplasms | en |
dc.subject | Male | en |
dc.subject | Middle Aged | en |
dc.subject | Neoplasm Invasiveness | en |
dc.subject | Neoplasm Staging | en |
dc.subject | Prognosis | en |
dc.subject | Survival Rate | en |
dc.subject | Tissue Array Analysis | en |
dc.subject | Vimentin | en |
dc.subject | International Institute of Anticancer Research | en |
dc.title | Epithelial-mesenchymal transition in non small-cell lung cancer | en |
dc.type | journalArticle | en |
Ficheros en el ítem
Ficheros | Tamaño | Formato | Ver |
---|---|---|---|
No hay ficheros asociados a este ítem. |